Content about Actos

February 25, 2013
Generic tsunami eases, but leaves transformed Rx landscape in its wake

The generic drug tidal wave became a tsunami in 2012, with some of the world's top-selling pharmaceuticals swamped by generic competition, and health plan payers scrambling to reap billions of dollars in financial savings.

October 24, 2012
Mylan hopes to stop Watson launch of diabetes drug

Mylan is challenging a federal court decision ordering the Food and Drug Administration to allow Watson Pharmaceuticals to launch a generic diabetes drug, Mylan said.

September 18, 2012
NewsBytes — Generics, 9/24/12

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


August 27, 2012
FDA approves generic version of Actos

The Food and Drug Administration has approved the first generic version of a diabetes drug made by Takeda, the agency said Friday.

August 17, 2012
Ranbaxy launches authorized generic diabetes drug

Ranbaxy Labs has launched an authorized generic version of a diabetes drug made by Takeda Pharmaceutical, Ranbaxy said Friday.

August 17, 2012
Teva launches authorized generic Actos

Teva Pharmaceutical Industries announced the launch of an authorized generic of a Type 2 diabetes drug.

August 15, 2012
Watson sues FDA over generic Actos

Watson Pharmaceuticals is suing the Food and Drug Administration, alleging that an agency decision would improperly delay its release of a generic drug for diabetes, the company said Wednesday.

July 30, 2012
Takeda resubmits diabetes drug applications

Drug maker Takeda Pharmaceutical has resubmitted regulatory approval applications for two drugs designed to treat diabetes, the company said.

April 26, 2012
FDA declines to approve Takeda diabetes drug

The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.

June 17, 2011
FDA updates ongoing safety review of Actos

The Food and Drug Administration on Thursday informed the public that continued use of a Type 2 diabetes treatment made by Takeda Pharmaceuticals for more than one year may be associated with an increased risk of bladder cancer.

March 25, 2011
Actos cuts Type 2 diabetes risk among majority of patients, study finds

A drug for Type 2 diabetes made by Takeda Pharmaceutical taken in the morning prevented the disease from developing in nearly three-quarters of patients who were at risk, according to a new study in the New England Journal of Medicine.

March 18, 2011
Journal notes heart-related risks posed by Avandia

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

November 14, 2010
Countdown to 2011: A big year for generics

The world of generic drugs has a big year ahead of it. Actually, it has...

November 14, 2010
Patent cliff to bring short-term boon to generic industry

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

September 16, 2010
FDA to review Actos for bladder cancer risk

The Food and Drug Administration said Friday it had begun a safety review of Takeda’s...

© 2013 Drug Store News. All Rights Reserved.